Fri, June 23, 2023
Thu, June 22, 2023
Wed, June 21, 2023
Tue, June 20, 2023
Mon, June 19, 2023
Fri, June 16, 2023
Thu, June 15, 2023
Wed, June 14, 2023

Vikram Purohit Reiterated (ASND) at Hold and Held Target at $109 on, Jun 20th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. old-and-held-target-at-109-on-jun-20th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vikram Purohit of Morgan Stanley, Reiterated "Ascendis Pharma A/S" (ASND) at Hold and Held Target at $109 on, Jun 20th, 2023.

Vikram has made no other calls on ASND in the last 4 months.



There are 6 other peers that have a rating on ASND. Out of the 6 peers that are also analyzing ASND, 2 agree with Vikram's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Initiated at Hold and Held Target at $89 on, Wednesday, June 14th, 2023
  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Wednesday, April 5th, 2023


These are the ratings of the 4 analyists that currently disagree with Vikram


  • Andreas Argyrides of "Wedbush" Reiterated at Buy and Held Target at $187 on, Wednesday, June 7th, 2023
  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $152 on, Thursday, June 1st, 2023
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $146 on, Wednesday, April 5th, 2023
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Decreased Target to $92 on, Tuesday, April 4th, 2023

Publication Contributing Sources